Compare CBL & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CBL | ENOV |
|---|---|---|
| Founded | 1978 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Fluid Controls |
| Sector | Real Estate | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.5B |
| IPO Year | 1995 | 2008 |
| Metric | CBL | ENOV |
|---|---|---|
| Price | $58.50 | $29.18 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 9 |
| Target Price | $45.00 | ★ $47.38 |
| AVG Volume (30 Days) | 279.6K | ★ 1.0M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | ★ 4.00% | N/A |
| EPS Growth | ★ 132.09 | N/A |
| EPS | ★ 1.48 | N/A |
| Revenue | ★ $578,373,000.00 | N/A |
| Revenue This Year | N/A | $6.36 |
| Revenue Next Year | N/A | $5.31 |
| P/E Ratio | $39.52 | ★ N/A |
| Revenue Growth | ★ 12.18 | N/A |
| 52 Week Low | $26.54 | $19.14 |
| 52 Week High | $60.40 | $34.28 |
| Indicator | CBL | ENOV |
|---|---|---|
| Relative Strength Index (RSI) | 65.12 | 60.91 |
| Support Level | $46.65 | $25.96 |
| Resistance Level | N/A | $29.29 |
| Average True Range (ATR) | 1.70 | 1.26 |
| MACD | 0.19 | 0.24 |
| Stochastic Oscillator | 74.61 | 73.42 |
CBL & Associates Properties Inc is a real estate investment trust. The company engages in the ownership, development, acquisition, leasing, management and operation of regional shopping malls, outlet centers, lifestyle centers, open-air centers and other properties. CBL's sales predominantly derive from leasing arrangements with retail tenants. The company also generates revenue from management and development fees, as well as sales of its real estate assets. CBL expands its portfolio of assets through activities such as redevelopment, renovation, and expansion.
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.